GuideView (NCT04838626) aimed to evaluate the safety and imaging efficacy of [18F]CTT1057 for the detection of PSMA-positive tumors, using histopathology as the standard of truth in patients with primary PCa planned for surgical therapy. Here, FOLH1 is linked to posterior cortical atrophy.